title: Response to "Analysis of adverse events of potential autoimmune aetiology in a large integrated safety database of AS04 adjuvanted vaccines" by Verstraeten et al.
authors.forename: Allan
authors.initials: A
authors.lastname: Hildesheim
authors.forename: Mark
authors.initials: M
authors.lastname: Schiffman
authors.forename: Diane
authors.initials: D
authors.lastname: Solomon
authors.forename: Sholom
authors.initials: S
authors.lastname: Wacholder
authors.forename: Ana Cecilia
authors.initials: AC
authors.lastname: Rodriguez
authors.forename: Rolando
authors.initials: R
authors.lastname: Herrero
mesh_terms: D000276:Adjuvants, Immunologic / Q000009:adverse effects* / Q000494:pharmacology; D000536:Aluminum Hydroxide / Q000009:adverse effects* / Q000494:pharmacology; D001327:Autoimmune Diseases / Q000139:chemically induced*; D006801:Humans; D008050:Lipid A / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000494:pharmacology; D014612:Vaccines / Q000009:adverse effects
chemical_list: C532963:ASO4 mixture; D000276:Adjuvants, Immunologic; D008050:Lipid A; D014612:Vaccines; D000536:Aluminum Hydroxide